| Indicators | Browse All

TherapeuticsMD, Inc. (TXMD)

Healthcare | Drug Manufacturers - Specialty & Generic | Boca Raton, United States | NasdaqGS
2.22 USD
After hours: 2.20 -0.02 (-0.020%) ⇩ (Aug. 28, 2026, 6:54 p.m. EDT)

Short-term:★☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | Aug. 22, 2026, 5:06 a.m. EDT

The investment case for TherapeuticsMD is fundamentally broken. The company has endured nine consecutive years of negative annual returns, with the stock price collapsing nearly 99.7% over the last decade. This is not a temporary setback; it is a structural implosion where the market has repeatedly rejected the business model. Fundamentals confirm the distress: the company is losing money, generating negative operating margins, and showing double-digit revenue contraction. While the balance sheet currently holds some cash, the relentless decline in both earnings and sales suggests the core product or strategy is failing to gain traction. There is no dividend to provide income, and the lack of analyst recommendations leaves the stock without institutional support. The recent news of a large stake by Baselake Group is a notable development, but given the magnitude of the price destruction, this appears to be a distressed accumulation rather than a sign of imminent recovery. For investors, the risk of permanent capital loss outweighs any speculative hope of a turnaround.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.037546
AutoETS0.037963
MSTL0.038642
AutoTheta0.039098

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 63%
H-stat 0.03
Ljung-Box p 0.000
Jarque-Bera p 0.562
Excess Kurtosis 0.35
Attribute Value
Sector Healthcare
Debt to Equity Ratio 20.492
Revenue per Share 0.283
Market Cap 25,695,084
Forward P/E 6.34
Beta 0.64
Profit Margins -6.64%
Website https://www.therapeuticsmd.com

As of Aug. 22, 2026, 5:06 a.m. EDT: Speculators are positioning heavily for downside protection, evidenced by significant open interest in out-of-the-money puts relative to calls. The call side shows minimal volume and open interest, while put open interest is concentrated at strikes below the current price, indicating a bearish bias among retail traders.


Info Dump

Attribute Value
52 Week Change 1.0943396
Address1 951 Yamato Road
Address2 Suite 220
All Time High 8,000.0
All Time Low 0.7
Ask 2.58
Ask Size 1
Audit Risk 9
Average Daily Volume10 Day 48,040
Average Daily Volume3 Month 42,441
Average Volume 42,441
Average Volume10Days 48,040
Beta 0.635
Bid 1.89
Bid Size 1
Board Risk 6
Book Value 2.33
City Boca Raton
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 6
Country United States
Crypto Tradeable 0
Currency USD
Current Price 2.22
Current Ratio 3.222
Custom Price Alert Confidence HIGH
Date Short Interest 1,786,665,600
Day High 2.2999
Day Low 2.22
Debt To Equity 20.492
Display Name TherapeuticsMD
Earnings Growth -0.806
Earnings Quarterly Growth -0.719
Earnings Timestamp End 1,755,259,200
Earnings Timestamp Start 1,754,909,940
Ebitda -1,369,000
Ebitda Margins -0.41865003
Enterprise To Ebitda -16.118
Enterprise To Revenue 6.748
Enterprise Value 22,066,084
Eps Forward 0.35
Eps Trailing Twelve Months -0.03
Esg Populated 0
Exchange NMS
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 2.0646
Fifty Day Average Change 0.15540004
Fifty Day Average Change Percent 0.075268835
Fifty Two Week Change Percent 109.43396
Fifty Two Week High 2.95
Fifty Two Week High Change -0.73
Fifty Two Week High Change Percent -0.24745762
Fifty Two Week Low 0.99
Fifty Two Week Low Change 1.23
Fifty Two Week Low Change Percent 1.2424242
Fifty Two Week Range 0.99 - 2.95
Financial Currency USD
First Trade Date Milliseconds 1,178,717,400,000
Float Shares 9,491,787
Forward Eps 0.35
Forward P E 6.3428574
Free Cashflow 896,625
Full Exchange Name NasdaqGS
Full Time Employees 1
Fullday Change 0.0
Fullday Change Percent 0.0
Fullday Price 2.2
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,785,542,400
Gross Margins 1.0
Gross Profits 3,270,000
Has Pre Post Market Data 1
Held Percent Insiders 0.09036
Held Percent Institutions 0.31803
Implied Shares Outstanding 11,574,362
Industry Drug Manufacturers - Specialty & Generic
Industry Disp Drug Manufacturers - Specialty & Generic
Industry Key drug-manufacturers-specialty-generic
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,652,054,400
Last Split Factor 1:50
Long Business Summary TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Long Name TherapeuticsMD, Inc.
Market us_market
Market Cap 25,695,084
Market State CLOSED
Max Age 86,400
Message Board Id finmb_114205175
Most Recent Quarter 1,782,777,600
Net Income To Common -295,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 25,695,083
Open 2.2999
Operating Cashflow 3,120,000
Operating Margins -0.32221
Overall Risk 5
Payout Ratio 0.0
Phone 561 961 1900
Post Market Change -0.01999998
Post Market Change Percent -0.9009
Post Market Price 2.2
Post Market Time 1,787,957,668
Previous Close 2.22
Price Hint 4
Price To Book 0.9527897
Price To Sales Trailing12 Months 7.857824
Profit Margins -0.066360004
Quick Ratio 2.651
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0
Regular Market Change Percent 0.0
Regular Market Day High 2.2999
Regular Market Day Low 2.22
Regular Market Day Range 2.22 - 2.2999
Regular Market Open 2.2999
Regular Market Previous Close 2.22
Regular Market Price 2.22
Regular Market Time 1,787,947,201
Regular Market Volume 19,328
Return On Assets -0.028789999
Return On Equity -0.01084
Revenue Growth -0.087
Revenue Per Share 0.283
Sand P52 Week Change 0.20504117
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 3
Shares Outstanding 11,574,362
Shares Percent Shares Out 0.0023999999
Shares Short 27,618
Shares Short Previous Month Date 1,784,073,600
Shares Short Prior Month 43,171
Short Name TherapeuticsMD, Inc.
Short Percent Of Float 0.0033000002
Short Ratio 1.52
Source Interval 15
State FL
Symbol TXMD
Total Cash 9,189,000
Total Cash Per Share 0.794
Total Debt 5,560,000
Total Revenue 3,270,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.03
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 2.0486
Two Hundred Day Average Change 0.17140007
Two Hundred Day Average Change Percent 0.08366693
Type Disp Equity
Volume 19,328
Website https://www.therapeuticsmd.com
Zip 33,431